colorectal-cancer
Probiotic-derived enzyme selectively kills colon cancer cells with extremely low effective dose.
Arginine deiminase (ADI) depletes arginine—an amino acid many cancer cells cannot synthesize themselves. This study tested a recombinant ADI from the probiotic bacterium Limosilactobacillus reuteri against HCT116 colorectal cancer cells.